Memory lapses, difficulty concentrating, and a sense of mental cloudiness—often referred to as “chemo brain”—affect as many as 75% of cancer patients and can last long after treatment ends. Now, researchers at the Fralin Biomedical Research Institute at VTC have found evidence that these cognitive issues may stem from disruptions in the brain’s lymphatic system caused by chemotherapy . The study, published in Communications Biology , provides a new avenue to study and potentially mitigate these long-term neurological side effects of chemotherapy.

“Our study is important because it explores a very real, hidden layer of chemotherapy treatment that leaves lasting scars on the daily lives of those who are living with or have survived in their cancer journey,” said co-lead author Monet R

See Full Page